Please login to the form below

Not currently logged in
Email:
Password:

MS

This page shows the latest MS news and features for those working in and with pharma, biotech and healthcare.

New data backs GeNeuro’s MS drug after Servier exit

New data backs GeNeuro’s MS drug after Servier exit

The data come from the ANGEL-MS trial, an extension of an earlier phase 2 study (CHANGE-MS), that had to be called to a halt after one year when Servier ... Its proposed mechanism doesn’t rely on an anti-inflammatory action, which means that it could

Latest news

More from news
Approximately 29 fully matching, plus 334 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    4. Mayzent – a latest addition to competitive MS market. Novartis’ Mayzent (siponimod) is expected to be launched in the US in Q1 for multiple sclerosis, with an EU launch to follow ... The company says its latest trial results are the first and

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    This gives it an advantage over rival MS drugs, which need to be either administered via infusion by nurses, or require greater monitoring, for example.

  • Tackling a formidable foe Tackling a formidable foe

    Convenience is very important to the patient and the physician.” But MS biology remains a formidable foe. ... MS, even thought they have the same genetic background. There are environmental factors, such as viruses possibly, at play.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    A great example is Sanofi Genzyme, whose MS solutions have been built around a long-term programme to understand the individual challenges of living with MS. ... The World versus MS’ has become a poster child for patient-centric engagement.

  • What can pharma learn from the charity sector? What can pharma learn from the charity sector?

    Georgina Carr, Head of External Relations and Campaigns at the MS Society, works with people with MS on a daily basis: “Co-creation has been key in the health charity sector ... We involve people affected by MS on all manner of things, from policy

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 46 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Alzheimers
Detecting Alzheimer’s ahead of a cure
A focus on promising new research...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...

Infographics